For INS-1 832/3, agonists were added in HBSS (acute incubations) or complete medium (prolonged incubations), at 11 mM glucose, at the time of seeding into plates
03 Research-only labeling Every vial is clearly identified for laboratory research and is not intended for human or veterinary consumption.

Chronic metabolic conditions are characterized by: Increased production of reactive oxygen species Impaired antioxidant defenses Mitochondrial dysfunction Chronic inflammation Cellular damage to pancreatic -cells, adipocytes, and hepatocytes How GLP-1 Affects Oxidative Stress Research has revealed that GLP-1 receptor agonists exert antioxidant effects through several mechanisms: Direct antioxidant signaling: Activation of the GLP-1 receptor triggers cellular pathways that reduce ROS production Anti-inflammatory effects: Decreases production of pro-inflammatory cytokines that contribute to oxidative stress Mitochondrial protection: Improves mitochondrial function and reduces oxidative damage Endothelial function: Enhances nitric oxide production and vascular health However, during weight loss especially rapid weight loss induced by GLP-1 RAs patients may experience increased oxidative stress due to the mobilization of stored toxins from adipose tissue

The mechanism by which it would help with pain-relief is not understood as it is typically used to supplement nutrient deficiencies more than anything else
NOTE TO PHARMACY CUSTOMERS: Notwithstanding the disclosures in this Policy, all pharmacy activities that involve Protected Health Information (PHI) as defined under the Health Insurance Portability & Accountability Act and related laws and regulations (collectively referred to as HIPAA) are subject to our posted HIPAA Notice of Privacy Practices
Proc Am Soc Clin Oncol 23:559, 2004